메뉴 건너뛰기




Volumn 30, Issue 2, 2000, Pages 95-100

Screening for Prostate Cancer Using Prostate-specific Antigen Alone as a First-line Checkup Parameter: Results of the Health Checkup System

Author keywords

Health checkup system; Prostate cancer; Prostate specific antigen (psa); Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 0034136812     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyd021     Document Type: Article
Times cited : (9)

References (22)
  • 3
    • 0027249364 scopus 로고
    • Histopathological comparison of stage a prostatic adenocarcinoma in Japan and the United States
    • in Japanese
    • Uchida K, Shimazui T, Ohtani M, Akaza H, Koiso K, Nemoto R, et al. Histopathological comparison of stage A prostatic adenocarcinoma in Japan and the United States. Nippon Hinyokika Gakkai Zasshi 1993;84:1119-26 (in Japanese).
    • (1993) Nippon Hinyokika Gakkai Zasshi , vol.84 , pp. 1119-1126
    • Uchida, K.1    Shimazui, T.2    Ohtani, M.3    Akaza, H.4    Koiso, K.5    Nemoto, R.6
  • 4
    • 0017723266 scopus 로고
    • Mass screening program for prostatic diseases with transrectal ultrasosnography
    • Watanabe H, Mishina T, Saitoh M. Mass screening program for prostatic diseases with transrectal ultrasosnography. J Urol 1977;117:746-8.
    • (1977) J Urol , vol.117 , pp. 746-748
    • Watanabe, H.1    Mishina, T.2    Saitoh, M.3
  • 6
    • 0029360360 scopus 로고
    • Prostate-specific antigen in mass screening for carcinoma of the prostate
    • Shimizu TS, Uchida T, Satoh J, Imai K, Yamanaka H. Prostate-specific antigen in mass screening for carcinoma of the prostate. Int J Urol 1995;2:257-60.
    • (1995) Int J Urol , vol.2 , pp. 257-260
    • Shimizu, T.S.1    Uchida, T.2    Satoh, J.3    Imai, K.4    Yamanaka, H.5
  • 7
    • 0023915022 scopus 로고
    • Clinical characteristics of prostate cancer detected by mass screening
    • Imai K, Zinbo S, Shimizu K, Yamanaka H, Kumasaka F, Sato J. Clinical characteristics of prostate cancer detected by mass screening. Prostate 1988;12:199-207.
    • (1988) Prostate , vol.12 , pp. 199-207
    • Imai, K.1    Zinbo, S.2    Shimizu, K.3    Yamanaka, H.4    Kumasaka, F.5    Sato, J.6
  • 8
    • 0029051106 scopus 로고
    • Early detection of prostate cancer; results of a prostate-specific antigen-based detection program in Japan
    • Egawa S, Suyama K, Ohori M, Kawakami T, Kuwao S, Hirokado K, et al Early detection of prostate cancer; results of a prostate-specific antigen-based detection program in Japan. Cancer 1995;76:463-72.
    • (1995) Cancer , vol.76 , pp. 463-472
    • Egawa, S.1    Suyama, K.2    Ohori, M.3    Kawakami, T.4    Kuwao, S.5    Hirokado, K.6
  • 11
    • 0026583502 scopus 로고
    • Serum prostate-specific antigen as pre-screening test for prostate cancer
    • Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez J, et al. Serum prostate-specific antigen as pre-screening test for prostate cancer. J Urol 1992;147:846-52.
    • (1992) J Urol , vol.147 , pp. 846-852
    • Labrie, F.1    Dupont, A.2    Suburu, R.3    Cusan, L.4    Tremblay, M.5    Gomez, J.6
  • 12
    • 0030448713 scopus 로고    scopus 로고
    • Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen
    • Morgan TO, McLeod DG, Leifer ES, Murphy GP and Moul JW. Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen Urology 1996;48(6A):76-80.
    • (1996) Urology , vol.48 , Issue.6 A , pp. 76-80
    • Morgan, T.O.1    McLeod, D.G.2    Leifer, E.S.3    Murphy, G.P.4    Moul, J.W.5
  • 13
    • 0024464835 scopus 로고
    • Clinical use of prostate-specific antigen in patients with prostate cancer
    • Hudson MA, Bahnson RR, Catalona WJ. Clinical use of prostate-specific antigen in patients with prostate cancer. J Urol 1989;142:1011-7.
    • (1989) J Urol , vol.142 , pp. 1011-1017
    • Hudson, M.A.1    Bahnson, R.R.2    Catalona, W.J.3
  • 14
    • 0028972366 scopus 로고
    • Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II. Early detection strategies
    • Coley C, Barry M, Fleming C, Wasson JH, Fans MC, Oesterling JE. Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II. Early detection strategies. Urology 1995;46:125-9.
    • (1995) Urology , vol.46 , pp. 125-129
    • Coley, C.1    Barry, M.2    Fleming, C.3    Wasson, J.H.4    Fans, M.C.5    Oesterling, J.E.6
  • 15
  • 16
    • 0023072182 scopus 로고
    • Incidental prostatic carcinoma diagnosed by step-section technique of surgical specimen; histopathological analysis
    • in Japanese
    • Uchida K, Ishikawa S, Nemoto R, Koiso K, Harada M. Incidental prostatic carcinoma diagnosed by step-section technique of surgical specimen; histopathological analysis. Nippon Hinyokika Gakkai Zasshi 1987;78:24-8 (in Japanese).
    • (1987) Nippon Hinyokika Gakkai Zasshi , vol.78 , pp. 24-28
    • Uchida, K.1    Ishikawa, S.2    Nemoto, R.3    Koiso, K.4    Harada, M.5
  • 17
    • 0023371894 scopus 로고
    • Early phase of prostatic carcinoma; correlation between rumor size and histopathological characteristics
    • in Japanese
    • Uchida K, Nemoto R, Koiso K, Harada M. Early phase of prostatic carcinoma; correlation between rumor size and histopathological characteristics. Nippon Hinyokika Gakkai Zasshi 1987;78:1185-90 (in Japanese).
    • (1987) Nippon Hinyokika Gakkai Zasshi , vol.78 , pp. 1185-1190
    • Uchida, K.1    Nemoto, R.2    Koiso, K.3    Harada, M.4
  • 18
    • 0027943285 scopus 로고
    • Early detection of prostate cancer: The nature of cancers detected with current diagnostic tests
    • Ohori M, Scardino PT. Early detection of prostate cancer: the nature of cancers detected with current diagnostic tests. Semin Oncol 1994;5:522-6.
    • (1994) Semin Oncol , vol.5 , pp. 522-526
    • Ohori, M.1    Scardino, P.T.2
  • 19
    • 0030744699 scopus 로고    scopus 로고
    • Prospective evaluation of prostate-specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate-specific antigen levels
    • Arai Y, Maeda H, Ishitoya S, Okubo K, Okada T, Aoki Y. Prospective evaluation of prostate-specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate-specific antigen levels. J Urol 1997;158:861-4.
    • (1997) J Urol , vol.158 , pp. 861-864
    • Arai, Y.1    Maeda, H.2    Ishitoya, S.3    Okubo, K.4    Okada, T.5    Aoki, Y.6
  • 20
    • 0031033363 scopus 로고    scopus 로고
    • The ratio of free to total serum prostate-specific antigen and its use in differential diagnosis of prostate carcinoma in Japan
    • Egawa S, Soh S, Ohori M, Uchida T, Gohji K, Fujii A, et al. The ratio of free to total serum prostate-specific antigen and its use in differential diagnosis of prostate carcinoma in Japan. Cancer 1997;79:90-8
    • (1997) Cancer , vol.79 , pp. 90-98
    • Egawa, S.1    Soh, S.2    Ohori, M.3    Uchida, T.4    Gohji, K.5    Fujii, A.6
  • 21
    • 0032550630 scopus 로고    scopus 로고
    • Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease; a prospective multicenter clinical trial
    • Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease; a prospective multicenter clinical trial J Am Med Assoc 1998,279:1542-7.
    • (1998) J Am Med Assoc , vol.279 , pp. 1542-1547
    • Catalona, W.J.1    Partin, A.W.2    Slawin, K.M.3    Brawer, M.K.4    Flanigan, R.C.5    Patel, A.6
  • 22
    • 0030986966 scopus 로고    scopus 로고
    • Prospective longitudinal evaluation of men with initial prostate-specific antigen levels of 4.0 ng/ml or less
    • Harris CH, Dalkin BL, Martub E, Marx PC, Ahmann FR. Prospective longitudinal evaluation of men with initial prostate-specific antigen levels of 4.0 ng/ml or less J Urol 1997;157:1740-3.
    • (1997) J Urol , vol.157 , pp. 1740-1743
    • Harris, C.H.1    Dalkin, B.L.2    Martub, E.3    Marx, P.C.4    Ahmann, F.R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.